Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation
Fujimoto AB, Keskinocak P, Yildirim I. Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation. Vaccine 2021, 39: 5055-5063. PMID: 34274126, PMCID: PMC8233959, DOI: 10.1016/j.vaccine.2021.06.067.Peer-Reviewed Original ResearchConceptsInfection attack rateAntibody testingSARS-CoV-2-specific antibodiesSpecific antibody testingAttack rateCOVID-19 vaccineSingle-dose vaccineCOVID-19 vaccine allocationDose vaccineSerology testingLimited vaccinesEligible individualsVaccine deploymentVaccination planVaccine supplySusceptible individualsNumber of casesRecovered (SIR) compartmental modelPeak dayUse of antibodiesVaccine allocationVaccinePeak infectionVaccinationSpecific antibodies
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply